Magnolia Medical Technologies Secures $13,800,000 Series B Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=04e12861-10a5-43bb-b207-4eea954a1a6a - Date
7/13/2016 - Company Name
Magnolia Medical Technologies - Mailing Address
2001 Sixth Avenue Seattle, WA 98121 USA - Company Description
Magnolia Medical Technologies has recently introduced the Initial Specimen Diversion Device (ISDD), a patented, Class I device registered and listed with FDA that is indicated to reduce the frequency of blood culture contamination. - Website
http://www.magnolia-medical.com - Transaction Type
Venture Equity - Transaction Amount
$13,800,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds from the financing will be used to accelerate commercialization of Magnolia Medical’s flagship product line, the SteriPath blood collection system. Funding will also support on-going development of the company’s planned roadmap of devices designed to eliminate human errors that cause false positive and false negative clinical laboratory test results. - M&A Terms
- Venture Investor
HealthQuest Capital - Venture Investor
Undisclosed
